Synthesized molecules studied as weapon to stop cell division in cancer cells

Blacksburg, Va., Aug. 23, 2004 -- An enzyme called Pin1, a gatekeeper of cell division, is present at high levels in a wide variety of cancer cells. Virginia Tech researchers who are designing small molecules to inhibit Pin1 are seeing promising results with a small U-shaped molecule.

Felicia Etzkorn, associate professor of chemistry, will report on her group's achievements in presentations at the 228th American Chemical Society (ACS) National Meeting in Philadelphia August 22-26.

Pin1 regulates the protein Cdc25, which initiates mitosis or cell division. Without Pin1, the cell enters programmed cell death -- which is good if it's a cancer cell.

"It makes sense to inhibit the Pin1 enzyme," said Etzkorn.

Protein shape determines biological function. Pin1 works by changing a peptide bond within Cdc25 from the trans shape (a flattened-Z shape) to the cis U-shape and back. This a simple change -- the swing of an arm one way or another to open or close the U results in a large conformation change in a protein.

The researchers synthesized cis and trans shaped inhibitors and introduced them into cancer cells. These inhibitors mimic part of the Cdc25 protein but do not bend to the will of Pin1. The research team discovered that cis inhibits the Pin1 enzyme's function 23 times better than trans. "This is very exciting because it tells us something fundamental about the mechanism.

The Etzkorn group tested the inhibitors in an ovarian cancer cell line. "That was the cell line that was available, but it should work for many cancers," Etzkorn said. "It would probably be particularly effective against breast cancer and prostate cancer. It seems to relate to secondary sexual characteristics."

However, a lot of work remains to be done to develop a drug, she cautions. "For instance, the inhibitor does not cross cell membranes. We can overcome that in the laboratory in order to study effectiveness, but have no

Contact: Susan Trulove
Virginia Tech

Page: 1 2 3

Related biology news :

1. Human Metabolite Of Taxol Synthesized In The Laboratory
2. Tiny molecules have big potential as cancer drugs, Stanford researcher believes
3. Scientists reinvent DNA as template to produce organic molecules
4. Sweet success in targeting sugar molecules to cells in living animals
5. UC Riverside researcher takes snapshots of the movement of molecules in a billionth of a second
6. Scientists pinpoint molecules that generate synapses
7. Two molecules work together to aid transport of immune cells, UT Southwestern researchers find
8. Controlling biomolecules with magnetic tweezers
9. Water molecules clump more loosely than previously thought
10. Creating polymers that act like biomolecules
11. A new way to see DNA (and other tiny molecules)

Post Your Comments:

(Date:6/4/2019)... ... , ... Lajollacooks4u is delighted to announce it has been named as one ... given only to businesses that have achieved consistently outstanding traveler reviews on TripAdvisor, as ... To qualify for the Certificate of Excellence –- an award that only 10 percent ...
(Date:5/31/2019)... ... May 30, 2019 , ... Researchers from Ambry Genetics ... significant differences in the prevalence of hereditary genetic mutations, also called germline mutations, ... women. Results will be presented at the 2019 American Society of Clinical Oncology ...
(Date:5/26/2019)... ... ... Zolgensma (Novartis, AveXis), an AAV-delivered gene therapy used to treat spinal muscular atrophy ... by the Food and Drug Administration today. , The treatment is now ... United States and the second-ever approved treatment for SMA. , FDA granted priority review ...
Breaking Biology News(10 mins):
(Date:6/18/2019)... ... ... Personalized Stem Cells, Inc (“PSC”), a human adipose-derived stem cell ... of a person’s own adipose-derived stem cells to treat their osteoarthritis. The first clinical ... IND is the first of several planned clinical trials which will enable qualified PSC-enrolled ...
(Date:6/11/2019)... ... June 11, 2019 , ... ... Clinic, a national leader in opioid treatment, announced today they are partnering to ... , Mytonomy recently deployed its virtual care platform at the Mayo Clinic to ...
(Date:5/31/2019)... City, California (PRWEB) , ... ... ... allowance of our patent applications from the USPTO providing proprietary interest to ... AND METHOD FOR SLEEP DISORDER DIAGNOSIS AND TREATMENT… extends Somnology’s IP rights ...
(Date:5/21/2019)... ABABA, Ethiopia (PRWEB) , ... May 21, 2019 ... ... für Brauerei in Berlin (VLB) today officially opened the inaugural Africa Brewing Conference ... brewing and malting industry in Africa. The event, which is supported through a ...
Breaking Biology Technology:
Cached News: